Challenging negative data helps AI models better identify effective antibodies

Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup